LicianPro

Gossamer Bio, Inc. ·

GOSS 8-K 2026-09-28

Gossamer Bio, Inc. (GOSS) 8-K dated 2026-09-28 — accession 0001728117-26-000106.

Gossamer Bio, Inc. (GOSS) is a biotechnology company listed on US.

Gossamer Bio, Inc. filed a 8-K on 2026-09-28. Accession 0001728117-26-000106.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GOSS revenue for 2025-12-31 was $48.5M. Net income was -$170.4M. Revenue was down 57.7% from 2024-12-31 to 2025-12-31. GOSS currently screens at market cap $47.0M.

Not investment advice. The GOSS SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr